We also performed univariate Cox regression analyses to identify prognostic factors for patients with pancreatic cancer and found that stages, treatments, CA19-9, and EphA2-NF were associated with a significantly poor prognosis of pancreatic cancer (Table 2). Here, EPHA2 is linked to familial pancreatic carcinoma.